Procept Biorobotics Corp (PRCT) Stock Price, Quote & News

Company Profile

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 232 7200

Website: www.procept-biorobotics.com

Address:

150 Baytech Drive, San Jose, United States

Stonkleader55 Jan. 13 at 9:17 PM

$PRCT this is a dogshit investment so far, what is going on?

1 · Reply

JackDarwin Jan. 6 at 1:16 PM

$PRCT Bullish Above the Stomach Candlestick Pattern Formed at Downtrend

0 · Reply

EcosystemEquity Dec. 24 at 11:08 AM

$PRCT Forward visibility remains uneven as execution velocity aligns with stated operational milestones. Failure to demonstrate progress would likely keep valuation capped.

0 · Reply

ARMRreport Dec. 19 at 7:23 PM

Hot off the press... The 2026 Medical Robotics Landscape: Industrialization & Integration #StocksToWatch $ISRG $GMED $RXRX $TEM $PRCT https://armrinvesting.substack.com/publish/post/182114397?utm_campaign=post-expanded-share&utm_medium=web #investing

0 · Reply

JarvisFlow Dec. 18 at 3:51 PM

Truist Securities has adjusted their stance on PROCEPT BioRobotics ( $PRCT ), setting the rating to Buy with a target price of 50 → 47.

0 · Reply

Muddymac Dec. 16 at 10:08 PM

$PRCT I like this company a lot, but be prepared for a rough patch until mid-‘26. I think they will struggle a bit this quarter and next getting sales and marketing back on track. Be ready to buy the dips.

0 · Reply

JarvisFlow Dec. 12 at 4:12 PM

UBS updates rating for PROCEPT BioRobotics ( $PRCT ) to Buy, target set at 62.

0 · Reply

aristocks Dec. 11 at 6:15 PM

$SYM and $PRCT are my robotics play! With now the government talking about robotics AND the FED money printing starting tomorrow for the next 6-7 months (to bail out AI and Scam Altm@n - ops sorry Sam), liquidity will flood the market, and hopefully big institutions (the one getting all the money printing) will start buying up! Only sad part, everyday Joes and Janes will keep suffering.. because the current FED and ADMIN instead of helping avg Americans, again choosing to help BIG companies.. but hey... it is, what it is..

2 · Reply

BootySqueeze Dec. 11 at 3:32 PM

$PRCT bottomed out for a robotics renaissance.

0 · Reply

Dragon_Awakened Dec. 10 at 9:43 PM

$PRCT $40 this week

0 · Reply

Where To Invest In 2026: Top 5 Secular Growth Trends

AMPX CHYM GH LSCC MOD

Nov 20, 2025, 4:03 PM EST - 7 weeks ago

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

Nov 20, 2025, 8:40 AM EST - 7 weeks ago

Artisan Global Discovery Fund: Q3 Delivers Strong Results Amid Trimming And Exits

BA BFAM CWAN EPS EW LSCC MOD

Nov 4, 2025, 9:36 PM EST - 2 months ago

PROCEPT BioRobotics Corporation (PRCT) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 4:03 PM EST - 2 months ago

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance

Oct 15, 2025, 4:03 PM EDT - 3 months ago

PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025

Oct 6, 2025, 12:30 PM EDT - 3 months ago

Procept BioRobotics: A Strong Challenger Positioned To Be A Future Leader

Aug 14, 2025, 5:24 PM EDT - 5 months ago

Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy

Aug 7, 2025, 2:17 AM EDT - 5 months ago

PROCEPT BioRobotics Corporation (PRCT) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:03 PM EDT - 5 months ago

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Jul 24, 2025, 6:00 PM EDT - 6 months ago

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

Jul 23, 2025, 8:00 AM EDT - 6 months ago

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy

Jul 21, 2025, 4:03 PM EDT - 6 months ago

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 14, 2025, 9:15 PM EDT - 6 months ago

Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

May 17, 2025, 7:00 AM EDT - 8 months ago

19 stocks at the intersection of AI and robotics that could see big sales boosts

AI AMBA CLS HSAI IOT ISRG NOW

Apr 29, 2025, 4:03 PM EDT - 9 months ago

PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June

Apr 24, 2025, 4:03 PM EDT - 9 months ago

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

Apr 24, 2025, 2:37 PM EDT - 9 months ago

PROCEPT BioRobotics Corporation (PRCT) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 7:00 AM EDT - 9 months ago

PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Apr 10, 2025, 4:03 PM EDT - 9 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

Mar 24, 2025, 8:00 AM EDT - 10 months ago

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

Mar 14, 2025, 8:00 AM EDT - 10 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

Mar 11, 2025, 4:42 AM EDT - 11 months ago

Procept BioRobotics: Strong Growth, But Profitability Seems Far Away

Feb 25, 2025, 4:02 PM EST - 11 months ago

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

Feb 7, 2025, 8:00 AM EST - 1 year ago

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

Jan 16, 2025, 9:00 AM EST - 1 year ago

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics (NASDAQ: PRCT)

Nov 26, 2024, 4:05 PM EST - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

Nov 26, 2024, 5:10 AM EST - 1 year ago

Procept BioRobotics: Continued Growth Runway Ahead

Oct 29, 2024, 8:43 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

Oct 28, 2024, 4:19 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

Oct 28, 2024, 2:17 PM EDT - 1 year ago

Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential

Oct 28, 2024, 10:32 AM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings Call Transcript

Oct 28, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

Oct 9, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

Oct 7, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

Aug 28, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

Aug 27, 2024, 8:30 AM EDT - 1 year ago

Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval

Aug 21, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

Aug 3, 2024, 9:23 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

Jul 15, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

Jun 17, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

Jun 3, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

May 13, 2024, 4:05 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

May 6, 2024, 8:00 AM EDT - 1 year ago

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

May 1, 2024, 12:56 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q1 2024 Earnings Call Transcript

May 1, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

Apr 23, 2024, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

Apr 4, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

Apr 2, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024

Stonkleader55 Jan. 13 at 9:17 PM

$PRCT this is a dogshit investment so far, what is going on?

1 · Reply

JackDarwin Jan. 6 at 1:16 PM

$PRCT Bullish Above the Stomach Candlestick Pattern Formed at Downtrend

0 · Reply

EcosystemEquity Dec. 24 at 11:08 AM

$PRCT Forward visibility remains uneven as execution velocity aligns with stated operational milestones. Failure to demonstrate progress would likely keep valuation capped.

0 · Reply

ARMRreport Dec. 19 at 7:23 PM

0 · Reply

JarvisFlow Dec. 18 at 3:51 PM

Truist Securities has adjusted their stance on PROCEPT BioRobotics ( $PRCT ), setting the rating to Buy with a target price of 50 → 47.

0 · Reply

Muddymac Dec. 16 at 10:08 PM

0 · Reply

JarvisFlow Dec. 12 at 4:12 PM

UBS updates rating for PROCEPT BioRobotics ( $PRCT ) to Buy, target set at 62.

0 · Reply

aristocks Dec. 11 at 6:15 PM

2 · Reply

BootySqueeze Dec. 11 at 3:32 PM

$PRCT bottomed out for a robotics renaissance.

0 · Reply

Dragon_Awakened Dec. 10 at 9:43 PM

$PRCT $40 this week

0 · Reply

Magic8BallResponse Dec. 10 at 5:32 PM

$PRCT Look for entry in 20's

0 · Reply

JarvisFlow Dec. 8 at 2:38 PM

B of A Securities updates rating for PROCEPT BioRobotics ( $PRCT ) to Neutral, target set at 55 → 38.

0 · Reply

JasonCO Dec. 5 at 3:17 PM

$PRCT bs

0 · Reply

J05hua Dec. 5 at 5:23 AM

$PRCT What's up with this one?

0 · Reply

JarvisFlow Dec. 2 at 5:52 PM

Morgan Stanley updates rating for PROCEPT BioRobotics ( $PRCT ) to Overweight, target set at 56 → 51.

0 · Reply

Oruveek70 Dec. 1 at 12:00 PM

$PRCT a quiet message stream. 🤔

0 · Reply

TheBoss1956 Nov. 20 at 11:19 PM

$PRCT wow what happened with this one?

2 · Reply

Alimzade16 Nov. 18 at 8:39 PM

$PRCT still bullish, will come to 50s until eoy

1 · Reply

Oruveek70 Nov. 16 at 11:02 PM

$PRCT 'a niche market' - near to 52 week lows. Robotics in all it's guises: surgical, subsea, nano robotics, AI ..you name it will draw interest as we head towards the end of 2025 and beyond, in my view. Not a recent article attached but got my attention. https://seekingalpha.com/article/4828093-procept-biorobotic-strong-challenger-positioned-to-be-future-leader

0 · Reply

flapinux Nov. 14 at 4:32 PM

$PRCT Check out the analyst price targets on this thing & the chart itself shows strong long term support is mid 20s. Time to build a nice position :)

0 · Reply

WAJeff Nov. 12 at 7:27 PM

$MSTR Easily the worst thing I bought all year. Put it at the top of the loser pile, ahead of even $PRCT

0 · Reply

Reanimated666 Nov. 12 at 7:27 PM

$PRCT Getting juicy under 30

0 · Reply

Market Cap	1.75B
Revenue (ttm)	224.50M
Net Income (ttm)	-91.41M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-40.72%
Debt to Equity Ratio	0.14

Volume	800,600
Avg Vol	1,475,940
Day's Range	N/A - N/A
Shares Out	55.88M
Stochastic %K	7%
Beta	0.99
Analysts	Strong Sell
Price Target	$50.73